Akari Therapeutics Correlations

AKTX Stock

USD 1.21 0.09 8.04%

The correlation of Akari Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Akari Therapeutics Correlation With Market

Good diversification

The correlation between Akari Therapeutics PLC and DJI is -0.05 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akari Therapeutics PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Moving together with Akari Stock

0.69	HLN	Haleon plc	Pair Corr
0.71	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.7	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.67	ANRO	Alto Neuroscience,	Pair Corr
0.66	SHG	Shinhan Financial	Pair Corr
0.75	BCH	Banco De Chile	Pair Corr
0.66	BA	Boeing Fiscal Year End 29th of January 2025	Pair Corr
0.83	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr

Moving against Akari Stock

0.88	TRV	The Travelers Companies Fiscal Year End 17th of January 2025	Pair Corr
0.87	AXP	American Express Fiscal Year End 24th of January 2025	Pair Corr
0.71	FNMFO	Federal National Mortgage Upward Rally	Pair Corr
0.69	KB	KB Financial Group	Pair Corr
0.66	ITCL	Banco Ita Chile	Pair Corr
0.58	CIB	Bancolombia SA ADR	Pair Corr
0.49	AVAL	Grupo Aval	Pair Corr
0.93	WMT	Walmart Aggressive Push	Pair Corr
0.89	CSCO	Cisco Systems Aggressive Push	Pair Corr
0.89	AA	Alcoa Corp Fiscal Year End 15th of January 2025	Pair Corr
0.88	DIS	Walt Disney Aggressive Push	Pair Corr
0.87	T	ATT Inc Aggressive Push	Pair Corr
0.86	BAC	Bank of America Aggressive Push	Pair Corr
0.84	CVX	Chevron Corp Sell-off Trend	Pair Corr
0.75	HD	Home Depot Sell-off Trend	Pair Corr
0.72	HPQ	HP Inc	Pair Corr
0.7	CAT	Caterpillar Fiscal Year End 3rd of February 2025	Pair Corr
0.44	IBM	International Business Fiscal Year End 22nd of January 2025	Pair Corr

Related Correlations Analysis

	ARMP	ANEB	SCPS	PCSA	SLRX	AXLA	MGTA	HSTO	PULM
ARMP		0.0	-0.24	0.13	0.0	0.03	0.01	0.37	-0.18	ARMP
ANEB	0.0		0.47	0.7	0.38	0.69	-0.58	0.5	-0.62	ANEB
SCPS	-0.24	0.47		0.31	-0.09	0.56	-0.52	0.1	-0.27	SCPS
PCSA	0.13	0.7	0.31		0.56	0.83	-0.52	0.71	-0.79	PCSA
SLRX	0.0	0.38	-0.09	0.56		0.17	-0.22	0.44	-0.37	SLRX
AXLA	0.03	0.69	0.56	0.83	0.17		-0.48	0.44	-0.65	AXLA
MGTA	0.01	-0.58	-0.52	-0.52	-0.22	-0.48		-0.56	0.57	MGTA
HSTO	0.37	0.5	0.1	0.71	0.44	0.44	-0.56		-0.76	HSTO
PULM	-0.18	-0.62	-0.27	-0.79	-0.37	-0.65	0.57	-0.76		PULM
	ARMP	ANEB	SCPS	PCSA	SLRX	AXLA	MGTA	HSTO	PULM

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

AXLA	+ 0.83	PCSA
HSTO	+ 0.71	PCSA
PCSA	+ 0.7	ANEB
AXLA	+ 0.69	ANEB
PULM	+ 0.57	MGTA
AXLA	+ 0.56	SCPS

High negative correlations

PULM	- 0.79	PCSA
PULM	- 0.76	HSTO
PULM	- 0.65	AXLA
PULM	- 0.62	ANEB
MGTA	- 0.58	ANEB
HSTO	- 0.56	MGTA

Risk-Adjusted Indicators

There is a big difference between Akari Stock performing well and Akari Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Akari Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ARMP	3.08	(0.01)	(0.02)	0.09	3.74	(3.95)	6.19	(7.05)	33.83
ANEB	5.00	(0.35)	0.00	(0.12)	0.00	0.00	8.61	(11.48)	76.00
SCPS	12.15	(0.23)	0.01	0.06	16.66	(15.32)	35.42	(24.69)	94.02
PCSA	2.77	(0.67)	0.00	(0.41)	0.00	0.00	6.20	(5.34)	20.99
SLRX	4.28	(0.25)	0.00	(0.09)	0.00	0.00	9.59	(9.15)	27.43
AXLA	3.96	(0.81)	0.00	0.70	0.00	0.00	7.69	(9.68)	39.29
MGTA	2.62	0.06	0.00	0.26	3.40	(3.33)	5.88	(4.29)	16.99
HSTO	4.52	(1.50)	0.00	(2.54)	0.00	0.00	4.76	(4.55)	131.40
PULM	5.60	2.53	0.52	(3.82)	3.19	(7.43)	16.69	(4.76)	92.85

Akari Therapeutics Corporate Management

Torsten Hombeck	Chief Officer	Profile
Annie Mack	Financial Controller	Profile
MD III	Executive Officer	Profile
Ray MD	Ex Chairman	Profile
BethAnne Lang	Senior Affairs	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC